Works matching IS 02776715 AND DT 2013 AND VI 32 AND IP 3
Results: 16
Comments on the FDA draft guidance on biosimilar products.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 3, p. 364, doi. 10.1002/sim.5572
- By:
- Publication type:
- Article
Statistical methods for assessing interchangeability of biosimilars.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 3, p. 442, doi. 10.1002/sim.5566
- By:
- Publication type:
- Article
Superchain procedures in clinical trials with multiple objectives.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 3, p. 486, doi. 10.1002/sim.5537
- By:
- Publication type:
- Article
Assessing biosimilarity and interchangeability of biosimilar products.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 3, p. 361, doi. 10.1002/sim.5577
- By:
- Publication type:
- Article
Flexible bivariate phase II clinical trial design incorporating toxicity and response on different schedules.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 3, p. 470, doi. 10.1002/sim.5671
- By:
- Publication type:
- Article
Application of the parallel line assay to assessment of biosimilar products based on binary endpoints Application of the parallel line assay to assessment of biosimilar products based on binary endpoints.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 3, p. 449, doi. 10.1002/sim.5565
- By:
- Publication type:
- Article
On the interchangeability of biologic drug products.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 3, p. 434, doi. 10.1002/sim.5569
- By:
- Publication type:
- Article
Statistical considerations in biosimilar clinical efficacy trials with asymmetrical margins.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 3, p. 393, doi. 10.1002/sim.5612
- By:
- Publication type:
- Article
Scientific considerations for assessing biosimilar products.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 3, p. 370, doi. 10.1002/sim.5571
- By:
- Publication type:
- Article
Statistical assessment of biosimilarity based on relative distance between follow-on biologics.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 3, p. 382, doi. 10.1002/sim.5582
- By:
- Publication type:
- Article
Adaptive linear rank tests for eQTL studies.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 3, p. 524, doi. 10.1002/sim.5593
- By:
- Publication type:
- Article
Comparability of critical quality attributes for establishing biosimilarity.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 3, p. 462, doi. 10.1002/sim.5564
- By:
- Publication type:
- Article
Dynamic semiparametric Bayesian models for genetic mapping of complex trait with irregular longitudinal data.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 3, p. 509, doi. 10.1002/sim.5535
- By:
- Publication type:
- Article
An adapted F-test for homogeneity of variability in follow-on biological products.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 3, p. 415, doi. 10.1002/sim.5568
- By:
- Publication type:
- Article
The evaluation of biosimilarity index based on reproducibility probability for assessing follow-on biologics.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 3, p. 406, doi. 10.1002/sim.5570
- By:
- Publication type:
- Article
Impact of variability on the choice of biosimilarity limits in assessing follow-on biologics.
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 3, p. 424, doi. 10.1002/sim.5567
- By:
- Publication type:
- Article